Fate Therapeutics Inc (FATE) Ownership

1.71 ↑0.00 (0.00%)
As of December 31, 1969, 7:00pm EST.

Institutional Ownership

Redmile Group, LLC is the biggest individual institutional holder of Fate Therapeutics Inc (FATE), owning a total of 13.2 million shares. Combined, the top 49 institutional holders of FATE own 141.17% of the company with a total of 155.9 million shares.

In the latest ownership report on September 30th 2024, the top 49 institutional holders decreased their combined ownership of FATE by 3.9 million shares. 7 institutions bought 4,286,726 total additional shares and increased their ownership by an average of 42.19%. However 9 institutions sold 8,207,006 total shares and decreased their ownership by an average of 15.93%.

Overall this is a negative sign as the number of shares owned by the top 20 institutional holders of Fate Therapeutics decreased by a net total of -3,920,280 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Redmile Group, LLC11.563%0.000%13,169,05702024-09-30
BlackRock Inc9.196%3.530%10,473,250357,1442024-09-30
Vanguard Group Inc9.135%-1.568%10,404,123-165,6912024-09-30
Deep Track Capital, LP4.893%0.000%5,572,60702024-09-30
State Street Corp4.612%-1.606%5,252,974-85,7152024-09-30
Boxer Capital LLC4.356%-39.618%4,960,910-3,255,0002024-09-30
Bellevue Group AG4.249%0.000%4,839,77902024-09-30
Citadel Advisors Llc3.760%-4.589%4,282,077-205,9492024-09-30
JPMorgan Chase & Co3.226%18.214%3,674,608566,1602024-09-30
Deerfield Management Co3.122%0.000%3,555,87102024-09-30
Johnson & Johnson2.967%0.000%3,379,06402024-09-30
D. E. Shaw & Co LP2.966%-17.172%3,377,650-700,2722024-09-30
Woodline Partners LP2.692%205.962%3,065,7472,063,7452024-09-30
Morgan Stanley - Brokerage Accounts2.690%-51.343%3,063,421-3,232,5572024-09-30
Baker Bros Advisors LP2.632%0.000%2,997,77202024-09-30
Goldman Sachs Group Inc2.479%20.219%2,823,403474,8492024-09-30
Dimensional Fund Advisors, Inc.2.300%22.942%2,619,017488,7372024-09-30
Assenagon Asset Management SA2.137%-5.457%2,434,198-140,5052024-09-30
Geode Capital Management, LLC1.983%0.483%2,258,24610,8632024-09-30
Vestal Point Capital LP1.479%-15.750%1,685,000-315,0002024-09-30
Orbimed Advisors, LLC1.476%23.996%1,680,580325,2282024-09-30
Jacobs Levy Equity Management, Inc.1.394%-6.275%1,587,900-106,3172024-09-30

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Redmile Group, LLC11.563%0.000%13,169,05702024-09-30
BlackRock Inc9.196%3.530%10,473,250357,1442024-09-30
Vanguard Group Inc9.135%-1.568%10,404,123-165,6912024-09-30
State Street Corporation7.057%331.634%8,036,6696,174,7502024-03-31
Capital World Investors5.683%-32.070%5,591,517-2,639,7952022-12-31
Deep Track Capital, LP4.893%0.000%5,572,60702024-09-30
State Street Corp4.612%-1.606%5,252,974-85,7152024-09-30
Boxer Capital LLC4.356%-39.618%4,960,910-3,255,0002024-09-30
Bellevue Group AG4.249%0.000%4,839,77902024-09-30
Citadel Advisors Llc3.760%-4.589%4,282,077-205,9492024-09-30
ARK Investment Management LLC4.294%-63.839%4,214,863-7,440,9702022-12-31
JPMorgan Chase & Co3.226%18.214%3,674,608566,1602024-09-30
Deerfield Management Co3.122%0.000%3,555,87102024-09-30
Johnson & Johnson2.967%0.000%3,379,06402024-09-30
D. E. Shaw & Co LP2.966%-17.172%3,377,650-700,2722024-09-30
Woodline Partners LP2.692%205.962%3,065,7472,063,7452024-09-30
Morgan Stanley - Brokerage Accounts2.690%-51.343%3,063,421-3,232,5572024-09-30
Baker Bros Advisors LP2.632%0.000%2,997,77202024-09-30
Goldman Sachs Group Inc2.479%20.219%2,823,403474,8492024-09-30
Dimensional Fund Advisors, Inc.2.300%22.942%2,619,017488,7372024-09-30
Artal Group S A2.638%0.000%2,600,00002023-03-31
Suvretta Capital Management, LLC2.251%0.000%2,562,8522,562,8522024-03-31
Holocene Advisors, LP2.221%0.000%2,527,7472,527,7472024-03-31
Assenagon Asset Management SA2.137%-5.457%2,434,198-140,5052024-09-30
Geode Capital Management, LLC1.983%0.483%2,258,24610,8632024-09-30
Monaco Asset Management1.919%18.144%2,183,228335,2842023-12-31
Adage Capital Partners Gp LLC1.880%25.882%2,140,000440,0002024-03-31
Millennium Management LLC2.094%230.246%2,064,2381,439,1772023-09-30
Casdin Capital, LLC1.801%0.000%2,050,00002023-12-31
Bank of America Corp1.744%3.436%1,985,73265,9562024-06-30
Two Sigma Advisers, LLC1.650%-2.892%1,876,900-55,9002023-12-31
Federated Hermes Inc1.626%-24.543%1,849,872-601,6722023-12-31
Acadian Asset Management LLC1.505%-24.858%1,714,124-567,0472024-03-31
Vestal Point Capital LP1.479%-15.750%1,685,000-315,0002024-09-30
Orbimed Advisors, LLC1.476%23.996%1,680,580325,2282024-09-30
Jacobs Levy Equity Management, Inc.1.394%-6.275%1,587,900-106,3172024-09-30
Two Sigma Investments LLC1.363%-6.093%1,550,659-100,6132023-12-31
T. Rowe Price Associates, Inc.1.523%-43.588%1,500,032-1,159,0262023-03-31
FMR Inc1.489%3.410%1,462,06548,2062022-09-30
VOLORIDGE INVESTMENT MANAGEMENT, LLC1.481%174.799%1,459,283928,2472023-03-31
HHG PLC1.466%-0.751%1,424,726-10,7872022-09-30
Rafferty Asset Management, LLC1.417%226.775%1,393,965967,3822023-03-31
Westfield Capital Management Company, LP1.409%-0.371%1,386,058-5,1592022-12-31
Renaissance Technologies Corp1.352%-26.152%1,332,919-472,0172023-03-31
Nikko Asset Management Americas Inc1.326%1.440%1,288,85818,2932022-09-30
Sumitomo Mitsui Trust Holdings Inc1.326%1.440%1,288,85818,2932022-09-30
Northern Trust Corp1.266%-0.339%1,248,212-4,2492023-09-30
GCM Grosvenor Holdings, LLC1.054%0.000%1,037,25602022-12-31
Credit Suisse First Boston (CSFB)1.030%-0.215%1,013,305-2,1872022-12-31

Mutual Fund Ownership

BB Biotech AG Ord is the biggest individual fund holder of Fate Therapeutics Inc (FATE), owning a total of 4.8 million shares. Combined, the top 54 mutual fund holders of FATE own 60.08% of the company with a total of 63.4 million shares.

In the latest ownership report on January 31st 2025, the top 54 fund holders increased their combined ownership of FATE by 23 thousand shares. 1 funds bought 1,256 total additional shares and increased their ownership by an average of 0.14%. However 3 funds sold 24,454 total shares and decreased their ownership by an average of 0.45%.

Overall this is a negative sign as the number of shares owned by the top 20 mutual funds holding Fate Therapeutics decreased by a net total of -23,198 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
iShares Russell 2000 ETF2.396%-0.755%2,728,296-20,7502025-01-31
iShares Russell 2000 Value ETF0.810%0.136%922,5011,2562025-01-31
Dimensional US Targeted Value ETF0.558%-0.376%635,047-2,3982025-01-31
iShares Biotechnology ETF0.540%-0.212%615,366-1,3062025-01-31
Schwab US Small-Cap ETF™0.383%0.000%436,50702025-01-31

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
BB Biotech AG Ord4.249%0.000%4,839,77902024-12-31
ARK Innovation ETF3.440%-46.157%3,342,938-2,865,7292022-12-31
ARK Genomic Revolution ETF3.245%-16.345%3,152,851-615,9982022-12-31
Vanguard Total Stock Mkt Idx Inv2.677%0.000%3,049,28502024-12-31
iShares Russell 2000 ETF2.396%-0.755%2,728,296-20,7502025-01-31
ARK Genomic Revolution2.769%-35.027%2,717,571-1,465,0622022-12-31
Vanguard Instl Ttl Stck Mkt Idx Tr2.600%0.000%2,562,68602023-03-31
Vanguard Strategic Equity Inv2.230%0.000%2,540,35402024-12-31
SPDR® S&P Biotech ETF2.055%1.443%2,340,99933,3062024-11-30
American Funds SMALLCAP World A2.224%-40.598%2,182,951-1,491,9492022-12-31
American Funds New Economy A1.922%0.039%1,887,0007372022-12-31
Capital Group New Economy Comp1.922%0.039%1,887,0007372022-12-31
ARK Disruptive Innovation Full Composite1.439%-80.286%1,412,353-5,751,6712022-12-31
Vanguard Institutional Extnd Mkt Idx Tr1.233%0.000%1,403,91802024-12-31
Vanguard Explorer Inv1.113%0.000%1,268,13302024-12-31
American Funds Growth Fund of Amer A1.241%-43.961%1,218,423-955,8262022-12-31
Capital Group Growth Fnd of Amer Comp1.241%-43.961%1,218,423-955,8262022-12-31
Vanguard Extended Market Index Investor1.169%-0.063%1,152,017-7232023-08-31
Vanguard Small Cap Index1.096%0.311%1,080,1633,3442023-11-30
BlackRock Advantage Small Cap Core Instl0.839%1.288%955,56212,1552024-12-31
T. Rowe Price New Horizons0.949%-13.279%931,034-142,5642022-12-31
iShares Russell 2000 Value ETF0.810%0.136%922,5011,2562025-01-31
Fidelity Small Cap Index0.804%-10.232%916,172-104,4292024-11-30
CS (Lux) Digital Health Equity SB USD0.926%0.000%900,00002022-12-31
Fidelity® Small Cap Index0.824%1.673%812,70113,3752023-10-31
DFA US Targeted Value I0.656%0.109%746,5528162024-12-31
Pictet-Global Megatrend Sel I USD0.711%-0.993%699,710-7,0172022-10-31
Biotech Growth Ord0.603%0.000%687,00002024-10-31
Federated Hermes MDT SCC Institutional0.586%0.000%666,78102024-06-30
iShares Russell 2000 Growth ETF0.665%-0.361%654,004-2,3702023-06-21
State St Russell Sm/Mid Cp® Indx NL Cl C0.561%-1.404%638,961-9,1002024-12-31
T. Rowe Price Health Sciences0.645%-2.760%635,972-18,0512023-09-30
Dimensional US Targeted Value ETF0.558%-0.376%635,047-2,3982025-01-31
iShares Biotechnology ETF0.540%-0.212%615,366-1,3062025-01-31
Vanguard Small Cap Growth Index Inv0.614%0.511%605,2913,0782023-11-30
Federated Hermes MDT SCG Institutional0.524%-37.171%596,416-352,8532023-12-31
Federated Hermes MDT Small Cap Growth IS0.524%-37.171%596,416-352,8532023-12-31
Direxion Daily S&P Biotech Bull 3X ETF0.521%0.000%593,14702024-05-30
Vanguard Strategic Small-Cap Equity Inv0.506%-24.023%576,317-182,2252024-06-30
Pictet-Biotech P USD0.581%-0.472%572,425-2,7162023-07-31
SPDR® S&P Kensho New Economies Comps ETF0.491%0.000%559,43602024-11-29
Invesco Dorsey Wright SmallCap Momt ETF0.460%0.000%523,95802024-06-30
Fidelity® Select Biotechnology0.526%42.646%516,787154,5002023-02-28
JPMorgan Small Cap Value I0.449%0.000%511,03102024-07-31
Fidelity Extended Market Index0.441%-0.255%502,676-1,2852024-12-31
JPMorgan US Small Company L0.421%-2.824%479,772-13,9412024-12-31
Vanguard Russell 2000 ETF0.417%1.390%475,2996,5162024-12-31
Vanguard Market Neutral I0.393%0.000%447,61202024-09-30
Jupiter Merian Glb Eq AbsRet I USD Acc0.453%20.214%446,95175,1562023-06-30
Schwab US Small-Cap ETF™0.383%0.000%436,50702025-01-31
DFA US Small Cap I0.358%0.000%407,80602024-12-31
JPM Thematics Genetic Thrps C2 Acc USD0.353%-2.424%402,255-9,9942024-09-30
Federated Hermes MDT Small Cap Core IS0.343%-41.417%390,620-276,1612024-09-30
Vanguard VIF Small Co Gr0.379%0.000%375,89902023-12-31

Discussions

Please log in or register to share your thoughts.

dandanaiwo

$FATE not happening this week or in the next months
just keep hodl!

0 Like Report
millimaker

$FATE we need those buyers and volume.

0 Like Report